Literature DB >> 26126782

Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.

Fraukje J M Pol1, Petra L M Zusterzeel2, Maaike A P C van Ham2, Danielle A T Kuijpers2, Johan Bulten3, Leon F A G Massuger2.   

Abstract

OBJECTIVE: This study was performed to determine whether satellite LVSI in women with early stage cervical carcinoma is an independent prognostic factor for recurrence and survival.
METHODS: A total of 210 eligible patients with FIGO stages IA2 and IB1 cervical carcinoma, who underwent radical hysterectomy or radical trachelectomy with pelvic lymphadenectomy between January 2000 and December 2012, were included. Variables studied included age, histology type, differentiation grade, tumor size (TS), depth of invasion (DI), lymph node metastasis (LNM), conjoined lymphovascular space invasion (LVSI) and satellite LVSI. Univariate and multivariate analyses were performed to define variables that best predict recurrence and survival.
RESULTS: Univariate analysis showed that differentiation grade, depth of invasion, tumor size, lymph node metastasis, and both conjoined LVSI and satellite LVSI were significantly associated with recurrence and survival. Using multivariate analysis, differentiation grade (HR 3.63, 95%-CI 1.51-8.72), conjoined LVSI (HR 5.95, 95%-CI 1.57-22.53) and satellite LVSI (HR 7.45, 95%-CI 3.03-18.27) were independent prognostic factors for recurrence; LNM (HR 5.55, 95%-CI 1.52-20.26) and satellite LVSI (HR 8.94, 95%-CI 2.43-32.95) were prognostic factors for overall survival. For patients with low-risk cervical cancer without LNM only satellite LVSI correlated significantly with disease-free and overall survival.
CONCLUSION: Differentiation grade, DI, TS, LNM, and conjoined LVSI as well as satellite LVSI were prognostic factors for DFS and OS. Satellite LVSI is the most important factor predicting DFS and OS in early stage cervical cancer, especially when lymph nodes are negative.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; LVSI; Pathology; Recurrence; Risk factor; Survival

Mesh:

Year:  2015        PMID: 26126782     DOI: 10.1016/j.ygyno.2015.06.035

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

Review 1.  The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.

Authors:  Maria Rosaria Raspollini; Sigurd F Lax; W Glenn McCluggage
Journal:  Virchows Arch       Date:  2018-05-24       Impact factor: 4.064

2.  Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis.

Authors:  Chen Xu; Yang Yu; Xiaoran Li; Hongzan Sun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-27       Impact factor: 9.236

3.  Combination of Radiomics and Machine Learning with Diffusion-Weighted MR Imaging for Clinical Outcome Prognostication in Cervical Cancer.

Authors:  Ankush Jajodia; Ayushi Gupta; Helmut Prosch; Marius Mayerhoefer; Swarupa Mitra; Sunil Pasricha; Anurag Mehta; Sunil Puri; Arvind Chaturvedi
Journal:  Tomography       Date:  2021-08-05

4.  Feasibility of an ADC-based radiomics model for predicting pelvic lymph node metastases in patients with stage IB-IIA cervical squamous cell carcinoma.

Authors:  Yan Yan Yu; Rui Zhang; Rui Tong Dong; Qi Yun Hu; Tao Yu; Fan Liu; Ya Hong Luo; Yue Dong
Journal:  Br J Radiol       Date:  2019-04-01       Impact factor: 3.039

5.  Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.

Authors:  Xingchen Zhou; Husheng Wang; Xipeng Wang
Journal:  J Gynecol Oncol       Date:  2016-10-27       Impact factor: 4.401

6.  The Impaction of Laparoscopic versus Laparotomy for Lymphovascular Space Invasion of Early Cervical Cancer: A Multicenter Retrospective Study.

Authors:  Wei Huang; Yina Wang; Fanchun Yang; Ning Luo; Guihai Ai; Yuliang Wu; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2022-02-14

7.  Amide proton transfer weighted imaging combined with dynamic contrast-enhanced MRI in predicting lymphovascular space invasion and deep stromal invasion of IB1-IIA1 cervical cancer.

Authors:  Qingling Song; Shifeng Tian; Changjun Ma; Xing Meng; Lihua Chen; Nan Wang; Liangjie Lin; Jiazheng Wang; Qingwei Song; Ailian Liu
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

8.  Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy.

Authors:  Zhilan Chen; Kecheng Huang; Zhiyong Lu; Song Deng; Jiaqiang Xiong; Jia Huang; Xiong Li; Fangxu Tang; Zhihao Wang; Haiying Sun; Lin Wang; Shasha Zhou; Xiaoli Wang; Yao Jia; Ting Hu; Juan Gui; Dongyi Wan; Ding Ma; Shuang Li; Shixuan Wang
Journal:  Onco Targets Ther       Date:  2016-05-27       Impact factor: 4.147

9.  Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.

Authors:  Petra L M Zusterzeel; Johanna W M Aarts; Fraukje J M Pol; Petronella B Ottevanger; Maaike A P C van Ham
Journal:  Oncologist       Date:  2020-05-11

10.  Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.

Authors:  Xiaoran Li; Chen Xu; Yang Yu; Yan Guo; Hongzan Sun
Journal:  BMC Cancer       Date:  2021-07-28       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.